Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSC Secretome in Sjogren's Syndrome
NCT07910526Phase 2Completed
- Sponsor
- Universitas Sebelas Maret Hospital
- Start
- May 2024
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell secretome in Sjogren's syndrome, sponsored by Universitas Sebelas Maret Hospital. Started May 2024; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cell secretome
03
Conditions
Sjogren's syndrome
Beyond the preview
Go deeper on NCT07910526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07910526.